Intervention

Aripiprazole High (24 - 30 mg/day)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

A Short Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaNCT01942161 · 2010-08-01

COMPLETED

Common conditions

Schizophrenia1

Leading sponsors

Otsuka Pharmaceutical Co., Ltd.1

Trial status mix

COMPLETED1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.